NCT05289037 COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial) Status COMPLETED Phase PHASE2
NCT05285384 Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine Status COMPLETED Phase NA
NCT05283954 Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea Status WITHDRAWN Phase PHASE2/PHASE3
NCT05283902 Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly Status COMPLETED Phase N/A
NCT05282199 Inspiratory Muscle Training in Post COVID-19 Infection Subjects Status COMPLETED Phase NA
NCT05282056 COVID-19 Volumetric Quantification on Computer Tomography Using Computer Aided Diagnostics Status COMPLETED Phase NA
NCT05279456 A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen) Status COMPLETED Phase PHASE3
NCT05279365 PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS Status UNKNOWN Phase PHASE2/PHASE3
NCT05279352 Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome Status UNKNOWN Phase PHASE2
NCT05277285 STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care Status UNKNOWN Phase PHASE2
NCT05277155 Trial to Study the Efficacy and Safety of BEJO Red Ginger in COVID-19 Patients With Mild Symptoms Status UNKNOWN Phase PHASE2/PHASE3
NCT05276375 Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19 Status COMPLETED Phase PHASE2
NCT05275933 Efficacy of TCM Capsules Lian Hua Qing Wen Jiao Nang in Mild COVID-19 Patients Status COMPLETED Phase PHASE2/PHASE3
NCT05275491 Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients Status COMPLETED Phase N/A
NCT05274373 Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization Status UNKNOWN Phase N/A
NCT05273541 Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT05273242 Add-on Study on WHO Solidarity Trial Plus for COVID-19 in Nepal Status UNKNOWN Phase PHASE4
NCT05271929 Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19 Status TERMINATED Phase PHASE3